{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T19:39:47Z","timestamp":1769283587082,"version":"3.49.0"},"reference-count":24,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":8667,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Haematology"],"published-print":{"date-parts":[[1985,8]]},"abstract":"<jats:p>248 patients with non\u2010Hodgkin lymphomas (NHL) were retrospectively analysed in an attempt to elucidate the risk factors, the prognostic importance and the therapeutic implications of blood involvement. Bone marrow involvement and large spleen were significantly correlated to leukaemic manifestations (P &lt;0.0001 and P &lt;0.0005, respectively); conversely no correlations were seen with bulky disease and symptoms. Among low\u2010grade malignant lymphomas (LGML) centroblastic\u2010centrocytic follicular and diffuse or diffuse and \u201cCLL\u201d subtypes were mostly associated with blood involvement (31% and 55%, respectively). Among high\u2010grade malignant lymphomas (HGML) lymphoblastic type is more frequently associated with blood involvement (42%) than the other subtypes. Blood involvement was not clearly correlated with the prognosis either in LGML (median survival 39 and 36 months for leukaemic and non\u2010leukaemic patients, respectively) or HGML (median survival 12 and 18 months, respectively), although a shorter survival of leukaemic than non\u2010leukaemic lymphoblastic lymphoma was observed (median survival 8 months versus 14 months, respectively). The poorer response rate to therapy of leukaemic patients (median duration of CR 22 and 5 months in LGML and HGML, respectively) as opposed to non\u2010leukaemic patients (median duration of CR 29 and 23 months, respectively) led us to consider an alternative treatment in such patients.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1985.tb01560.x","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T15:50:37Z","timestamp":1280937037000},"page":"123-131","source":"Crossref","is-referenced-by-count":10,"title":["Non\u2010Hodgkin's lymphomas in leukaemic phase: Incidence, prognosis and therapeutic implications"],"prefix":"10.1111","volume":"35","author":[{"given":"Sante","family":"Tura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizio","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Lauria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Fiacchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Pileri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Poletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Gherlinzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Cantore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Bandini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197508)36:2<428::AID-CNCR2820360218>3.0.CO;2-H"},{"key":"e_1_2_1_3_2","first-page":"88","volume-title":"Recent results in cancer research. Lymphoid neoplasias. Vol. II. Clinical and therapeutic aspects","author":"Mathe' G.","year":"1978"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1979.tb03696.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood.V54.6.1417.1417","article-title":"Incidence and patterns of bone marrow and blood involvement by lymphoma in relationship to the Lukes\u2010Collins classifications","volume":"54","author":"Foucar K.","year":"1979","journal-title":"Blood"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1182\/blood.V55.5.792.792","article-title":"Detection of tumor cells in the peripheral blood of non leukaemic patients with B cell lymphoma: analysis of \u201cclonal excess\u201d","volume":"55","author":"Ligler FS","year":"1980","journal-title":"Blood"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(80)90416-7"},{"key":"e_1_2_1_8_2","first-page":"15","article-title":"Leukemic phase of non\u2010Hodgkin's lymphomas. Hematological features and prognostic significance","volume":"69","author":"Morra E.","year":"1984","journal-title":"Haematologica"},{"key":"e_1_2_1_9_2","volume-title":"Tumor of the hematopoietic system in: Atlas of tumor pathology","author":"Rappaport H.","year":"1966"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197410)34:8 <1488::AID-CNCR2820340822>3.0.CO;2-C"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1975.tb00911.x"},{"key":"e_1_2_1_12_2","volume-title":"WHO International Histological Classification of Tumors","author":"Mathe' G.","year":"1976"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19811201)48:11<2347::AID-CNCR2820481102>3.0.CO;2-X"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830071112"},{"key":"e_1_2_1_15_2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0308-2261(82)80009-X","article-title":"T\u2010cell subpopulations. Monoclonal antibodies and their therapeutic application","volume":"11","author":"Janossy G.","year":"1982","journal-title":"Clin Haematol"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1977.1"},{"key":"e_1_2_1_18_2","first-page":"60","article-title":"Follicular lymphoma: a survey of 75 cases with special reference to the syndrome resembling chronic lymphocytic leukaemia","volume":"31","author":"Spiro S.","year":"1975","journal-title":"Br J Cancer"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19831001)52:7<1220::AID-CNCR2820520716>3.0.CO;2-G"},{"key":"e_1_2_1_20_2","first-page":"178","article-title":"Non Hodgkin's lymphomas: pronostic features of 55 patients treated with MEVAP chemotherapy","volume":"2","author":"Mazza P.","year":"1984","journal-title":"Haematologica"},{"key":"e_1_2_1_21_2","first-page":"233","article-title":"Hydroxyldaunomycin (Adriamycin) combination chemotherapy in non\u2010Hodgkin's lymphomas","volume":"16","author":"McKelvey EM","year":"1975","journal-title":"ASCO abstracts"},{"issue":"13","key":"e_1_2_1_22_2","first-page":"161","article-title":"Autologous bone marrow transplant (ABMT) following super\u2010intensive chemotherapy in untreated non Hodgkin's lymphomas (NHL)","volume":"11","author":"Ricci P.","year":"1983","journal-title":"Exp Haematol"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-76-2-227"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00363890"},{"key":"e_1_2_1_25_2","unstructured":"SienaS. MalaspinaHC GulatiS. et al.In vitro purging with Hydroperoxycyclophosphamide (4\u2010HC) and its effects on hematopoietic and stromal elements of human bone marrow. Abstract book 2nd International Conference of Malignant Lymphoma. Lugano Switzerland 13\u201316 June 1984; 92:62."}],"container-title":["Scandinavian Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1985.tb01560.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1985.tb01560.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T06:55:12Z","timestamp":1697784912000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1985.tb01560.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,8]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1985,8]]}},"alternative-id":["10.1111\/j.1600-0609.1985.tb01560.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1985.tb01560.x","archive":["Portico"],"relation":{},"ISSN":["0036-553X"],"issn-type":[{"value":"0036-553X","type":"print"}],"subject":[],"published":{"date-parts":[[1985,8]]}}}